NRP1 and neoplasm: PC-3 tumor lysates had high NRP1 mRNA and protein expression and a wide ER-472 therapeutic window, versus minimal or no NRP1 detected in the MIA PaCa-2 and BxPC-3 tumor models where ER-472 was less effective (Fig. 4a and b).